Fat Loss

SLU-PP-332 Blend

Exercise mimetic ERR agonist blend

The exercise mimetic — ERR agonism for endurance and fat oxidation.

Vial

50 mg

BAC Water

5 mL

Dose

5 mg

Units on 1 mL

Timing

AM (pre workout)

Frequency

5 days on, 2 days off

Duration

6–8 weeks on, 4 weeks off

Note: Non peptide small molecule; boosts endurance and fat oxidation.

Also sold as

Research chemical vendors can't legally label products with the real name, so SLU-PP-332 Blend often appears under coded SKUs. If you're shopping and see any of these, it's the same compound:

SLU-PP-332
SLUPP332
Exercise Mimetic

Codes shown are for identification only.

Your draw

50 units · 5 mg

On a standard 100-unit / 1 mL insulin syringe.

What it actually is

SLU-PP-332 is a small molecule agonist of estrogen related receptors (ERRα/β/γ). In mice it produced endurance and metabolic changes that look like the effects of consistent aerobic training — improved fat oxidation, mitochondrial biogenesis, and running capacity — without the training itself.

Not a peptide — it's a small molecule. Dose AM pre training. Long term human safety data is limited.

Why people use it

Endurance and stamina support during cuts
Improved fat oxidation without appetite suppression
Users combining with GLP-1s to preserve output
Curiosity about 'exercise in a vial' research

Educational only · Not a vendor claim

How it works

Small molecule agonist of estrogen related receptors (ERRα/β/γ) that upregulates mitochondrial biogenesis, fat oxidation, and endurance related gene expression — mimicking many transcriptional effects of aerobic training.

Health benefits

Improved endurance and stamina
Higher fat oxidation at rest and during exercise
Mitochondrial support
Preserved output during caloric deficits

What you'll feel

Better cardio capacity within 2–4 weeks
Steadier energy through long training sessions
Fat loss without appetite change

Pros

Non hormonal, non stimulant
Stacks cleanly with GLP-1s to preserve output
Novel mechanism for endurance athletes

Cons

Not a peptide — small molecule with different pharmacokinetics
Limited human data
Doesn't replace training, only amplifies its signals

Side effects to know

Sleep disruption if dosed too late
Mild GI effects in some users

Best suited for

Endurance athletesUsers cutting on GLP-1sLongevity and mitochondrial protocolsResearch users curious about exercise mimetics

Educational summary · Not medical advice · Discuss with a qualified clinician

What to expect

Typical timeline

General pattern for the Fat Loss category. Individual response varies.

Week 1
Titrate up slowly. Expect appetite drop, mild nausea, and possible constipation with GLP-1s. Hydrate and lean on fiber.
Weeks 2–4
Steady weight trend down (0.5–1.5 lb/week is healthy). Prioritize protein (~1 g/lb lean mass) to protect muscle.
Weeks 4–8
Body composition visibly shifts. Add resistance training if you haven't — muscle preservation is the whole game.
Weeks 8+
Re-evaluate dose. Consider a maintenance drop or a scheduled break to reset receptor sensitivity.

Was this page helpful?

The reconstitution math

1Reconstitute the 50 mg vial with 5 mL of bacteriostatic water. Tilt — don't shake.
2Concentration becomes 10,000 mcg/mL (10 mg/mL).
3For a 5 mg dose, draw 0.500 mL — that's 50 units on a 1 mL insulin syringe.
4One vial gives you approximately 10 doses.

Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.

Dose log

Dose logging is available for signed-in users. Track today's dose and notes for SLU-PP-332 Blend.